The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
Open accessAbstract
Huntington’s disease (HD) is a progressive, multifaceted neurodegenerative disease associated with weight loss and gut problems. Under healthy conditions, tight junction (TJ) proteins maintain the intestinal barrier integrity preventing bacterial translocation from the intestinal lumen to the systemic circulation. Reduction of TJs expression in Parkinson’s disease patients has been linked with increased intestinal permeability—leaky gut syndrome. The intestine contains microbiota, most dominant phyla being Bacteroidetes and Firmicutes ; in pathogenic or disease conditions the balance between these bacteria might be disrupted. The present study investigated whether there is evidence for an increased intestinal permeability and dysbiosis in the R6/2 mouse model of HD. Our data demonstrate that decreased body weight and body length in R6/2 mice is accompanied by a significant decrease in colon length and increased gut permeability compared to wild type littermates, without any significant changes in the protein levels of the tight junction proteins (occludin, zonula occludens). Moreover, we found an altered gut microbiota in R6/2 mice with increased relative abundance of Bacteroidetes and decreased of Firmicutes . Our results indicate an increased intestinal permeability and dysbiosis in R6/2 mice and further studies investigating the clinical relevance of these findings are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the study did not observe an increase in Bacteroidetes and a reduction in Firmicutes, as reported in both R6/1 and R6/2 mice.235,236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
In the citing paper
“It was found that R6/2 mice exhibited increased intestinal permeability and reduced colon length at 16 weeks of age (early-mid disease stage), as compared to age-matched WT mice.236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
In the citing paper
“Moreover, a higher relative abundance of Bacteroidetes and a lower relative abundance of Firmicutes were reported in both R6/1 and R6/2 mice, as compared to WT mice.235,236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,246
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Quality control and preprocessing of metagenomic datasets
Schmieder, R., & Edwards, R. A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr026 · Cited by 5,119
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Aburto, M. R., & Cryan, J. F. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00890-0 · Cited by 407
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Current and Possible Future Therapeutic Options for Huntington’s Disease
Ferguson, M. W., Kennedy, C. J., Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221092517 · Cited by 133
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
Shukla, P. K., Delotterie, D. F., Xiao, J., Pierre, J. F., Rao, R., McDonald, M. P., & Khan, M. M. (2021) · Cells · doi:10.3390/cells10040779 · Cited by 105
Neurodegenerative disorders and gut-brain interactions
Singh, A., Dawson, T. M., & Kulkarni, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143775 · Cited by 104
Parodi, B., & de Rosbo, N. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718220 · Cited by 114
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
Bile acids and neurological disease
Hurley, M. J., Bates, R., Macnaughtan, J., & Schapira, A. H. V. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108311 · Cited by 86
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Toledo, A. R. L., Monroy, G. R., Salazar, F. E., Lee, J.-Y., Jain, S., Yadav, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031184 · Cited by 83
Twardowska, A., Makaro, A., Binienda, A., Fichna, J., & Sałaga, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063204 · Cited by 84
Altered Cholesterol Homeostasis in Huntington’s Disease
Kacher, R., Mounier, C., Caboche, J., & Bétuing, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.797220 · Cited by 74
Gubert, C., Choo, J. M., Love, C. J., Kodikara, S., Masson, B. A., Liew, J. J. M., Wang, Y., Kong, G., Narayana, V. K., Renoir, T., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac205 · Cited by 71
Shabbir, U., Tyagi, A., Elahi, F., Aloo, S. O., & Oh, D. (2021) · Antioxidants · doi:10.3390/antiox10091370 · Cited by 71
Cheng, W., Ho, J. Y. S., & Chang, R. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101620 · Cited by 71
Psoriasis: Interplay between dysbiosis and host immune system
Kapoor, B., Gulati, M., Rani, P., & Gupta, R. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103169 · Cited by 62
The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Ekwudo, M. N., Gubert, C., & Hannan, A. J. (2024) · FEBS Journal · doi:10.1111/febs.17102 · Cited by 61
Dang, G., Wen, X., Zhong, R., Wu, W., Tang, S., Li, C., Yi, B., Chen, L., Zhang, H., & Schroyen, M. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00838-z · Cited by 54
Arnone, A. A., & Cook, K. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac177 · Cited by 53
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Nguyen, N. M., Cho, J., & Lee, C.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044047 · Cited by 60
Effects of gut microbiota on neurodegenerative diseases
Khatoon, S., Kalam, N., Rashid, S., & Bano, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1145241 · Cited by 55
Gene targeting techniques for Huntington’s disease
Fields, E., Vaughan, E., Tripu, D. R., Lim, I., Shrout, K., Conway, J., Salib, N., Lee, Y., Dhamsania, A., Jacobsen, M., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101385 · Cited by 53
Dietary fibre confers therapeutic effects in a preclinical model of Huntington’s disease
Gubert, C., Kong, G., Costello, C., Adams, C. D., Masson, B. A., Qin, W., Choo, J. M., Narayana, V. K., Rogers, G. B., Renoir, T., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.023 · Cited by 45
Alterations in the Gut Fungal Community in a Mouse Model of Huntington’s Disease
Kong, G., Cao, K. L., & Hannan, A. J. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02192-21 · Cited by 43
Gubert, C., Love, C. J., Kodikara, S., Mei Liew, J. J., Renoir, T., Lê Cao, K.-A., & Hannan, A. J. (2022) · iScience · doi:10.1016/j.isci.2021.103687 · Cited by 41
Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment
Zou, X., Zou, G., Zou, X., Wang, K., & Chen, Z. (2024) · PeerJ · doi:10.7717/peerj.17061 · Cited by 51
Meng, Q., Zhang, Y., Li, J., Shi, B., Ma, Q., & Shan, A. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac208 · Cited by 37
What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
Przybył, Ł., Woźna, M., Kozłowska, E., & Fiszer, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041561 · Cited by 33
Gut Bacteria Regulate the Pathogenesis of Huntington’s Disease in Drosophila Model
Chongtham, A., Yoo, J. H., Chin, T. M., Akingbesote, N. D., Huda, A., Marsh, J., & Khoshnan, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.902205 · Cited by 30
Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
Sterling, K. G., Dodd, G. K., Alhamdi, S., Asimenios, P. G., Dagda, R. K., Meirleir, K. L. D., Hudig, D., & Lombardi, V. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113328 · Cited by 34
What the Gut Tells the Brain—Is There a Link between Microbiota and Huntington’s Disease?
Wronka, D., Karlik, A., Misiorek, J. O., & Przybył, Ł. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054477 · Cited by 32
Refisch, A., Şen, Z. D., Klassert, T. E., Busch, A., Besteher, B., Danyeli, L. V., Helbing, D. L., Schulze‐Späte, U., Stallmach, A., Bauer, M. W., et al. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109568 · Cited by 33
Inflammation and Huntington’s disease – a neglected therapeutic target?
Field, S., Curle, A. J., & Barker, R. A. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2348738 · Cited by 31
Sleep apnoea, gut dysbiosis and cognitive dysfunction
Deyang, T., Baig, M., Dolkar, P., Hediyal, T. A., Rathipriya, A. G., Bhaskaran, M., Pandi-Perumal, S. R., Monaghan, T. M., Mahalakshmi, A. M., & Chidambaram, S. B. (2023) · FEBS Journal · doi:10.1111/febs.16960 · Cited by 25
Yu, C., Liu, S., Niu, Y., & Fu, L. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109059 · Cited by 23
Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders
Villavicencio-Tejo, F., Olesen, M. A., Navarro, L., Calisto, N., Iribarren, C., GARCÍA, K. P., Corsini, G., & Quintanilla, R. A. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00681-0 · Cited by 24
Weng, C., Lee, M.-J., Chao, W., Lin, Y.-R., Chou, C.-J., Chen, M.-C., Chou, C., Tsai, I., Lin, C., Chung, K. F., et al. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.07.003 · Cited by 23
Gut Microbiota as a Modifier of Huntington’s Disease Pathogenesis
Khoshnan, A. (2024) · Journal of Huntington s Disease · doi:10.3233/jhd-240012 · Cited by 24
Balakrishnan, R., Kang, S.-I., Lee, J. Y., Rho, Y., Kim, B.-K., & Choi, D. (2024) · Aging and Disease · doi:10.14336/ad.2024.1362 · Cited by 22
Sochaczewska, D., Ziętek, M., Dołęgowska, B., Kordek, A., & Szczuko, M. (2022) · Nutrients · doi:10.3390/nu14112224 · Cited by 21
Multi-omics studies reveal ameliorating effects of physical exercise on neurodegenerative diseases
Guo, Y., Wang, S., Chao, X., Li, D., Wang, Y., Guo, Q., & Chen, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1026688 · Cited by 26
Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder
Trujillo-Del Río, C., Tortajada-Pérez, J., Gómez-Escribano, A. P., Casterá, F., Peiró, C., Millán, J. M., Herrero, M. J., & Vázquez-Manrique, R. P. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111670 · Cited by 19
Luo, S., Pan, M., Fu, G., Meng, X., Zhao, Z., Yu, H., Yue, G.-X., & Lei, T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107974 · Cited by 19
Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases
Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 20
Rajesh, K. M., Kinra, M., Ranadive, N., Pawaskar, G. M., Mudgal, J., & Raval, R. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02710-3 · Cited by 18
Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease
Martínez‐Lazcano, J. C., González‐Guevara, E., Boll, M., & Cárdenas, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0164 · Cited by 16
Programming Factors of Neonatal Intestinal Dysbiosis as a Cause of Disease
Jovandarić, M. Z., Dugalić, S., Babić, S., Babović, I. R., Milićević, S., Mihajlovic, D., Culjic, M., Zivanovic, T., Trklja, A., Marković, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065723 · Cited by 20
Effect of Body Weight on Age at Onset in Huntington Disease
van der Burg, J. M. M., Weydt, P., Landwehrmeyer, G. B., & Aziz, N. A. (2021) · Neurology Genetics · doi:10.1212/nxg.0000000000000603 · Cited by 15
The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review
Yin, J.-T., Xu, X., Jin, C.-Y., Yuan, X., & Wang, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2202038 · Cited by 15
Emerging pharmacological approaches for Huntington's disease
Singh, K., Jain, D., Sethi, P., Gupta, J. K., Tripathi, A. K., Kumar, S., Sarker, S. D., Nahar, L., & Guru, A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176873 · Cited by 15
Tang, W., Wang, Q., Sun, M., Liu, C., Huang, Y., Zhou, M., Zhang, X., Meng, Z., & Zhang, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122952 · Cited by 14
The microbiota-gut-brain axis in Huntington's disease
Love, C. J., Masson, B. A., Gubert, C., & Hannan, A. J. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.06.005 · Cited by 14
Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
Mitra, S., Munni, Y. A., Dash, R., Sadhu, T., Barua, L., Islam, M. A., Chowdhury, D., Bhattacharjee, D., Mazumder, K., & Moon, I. S. (2023) · Life · doi:10.3390/life13040957 · Cited by 13
Li, X., Jiang, B., Gao, T., Nian, Y., Bai, X., Zhong, J., Qin, L., Gao, Z., Wang, H., & Ma, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-02034-9 · Cited by 15
Saadh, M. J., Ahmed, H. H., Kareem, R. A., Sanghvi, G. V., Ganesan, S., Agarwal, M., Kaur, P., Taher, W. M., Alwan, M., Jawad, M. J., et al. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.173972 · Cited by 12
Ekwudo, M. N., Masson, B. A., Natale, M. R. D., Kiridena, P., van de Garde, N., Lei, E., Sarkar, S. K., Narayana, V. K., Renoir, T., Furness, J. B., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106074 · Cited by 11
Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J. (2023) · Epigenomics · doi:10.2217/epi-2023-0342 · Cited by 20
Tao, H., Wang, J., Bao, Z., Jin, Y., & Xiao, Y. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165038 · Cited by 9
Advances in Autophagy–Lysosomal Pathway and Neurodegeneration via Brain–Gut Axis
Yao, P., & Han, H. (2025) · Biomedicines · doi:10.3390/biomedicines13061390 · Cited by 10
Zhu, H., He, H., Yang, M., Zhu, H., Hagiwara, A., Shu, L., Xu, J., Miao, Y., Han, X., & Wang, C. (2025) · iScience · doi:10.1016/j.isci.2025.114044 · Cited by 8
Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective
Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 11
Gu, Y., Wang, M., & Mao, Y. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101247 · Cited by 9
Chiang, P.-I., Chang, K., Tang, H.-Y., Wu, Y., Cheng, M., & Chen, C. (2024) · Metabolites · doi:10.3390/metabo14070394 · Cited by 8
Brain–Periphery Interactions in Huntington’s Disease: Mediators and Lifestyle Interventions
Burtscher, J., Strasser, B., Pepe, G., Burtscher, M., Kopp, M., Pardo, A. D., Maglione, V., & Khamoui, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094696 · Cited by 8
Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder
Vashishth, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102466 · Cited by 8
Zhao, X.-N., McHugh, C. A., Coffey, S. R., Jimenez, D. A., Adams, E., Carroll, J. B., & Usdin, K. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049453 · Cited by 7
The role of the gut microbiome in Parkinson’s disease
Metcalfe‐Roach, A., & Finlay, B. B. (2025) · Future Neurology · doi:10.1080/14796708.2025.2494981 · Cited by 6
McGuire, B. D., Dees, A. N., Hao, L., Buckendahl, P., Ogilvie, A. R., Sun, H., Rezaee, T., Barrett, L. O., Karim, L., Domínguez-Bello, M. G., et al. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106314 · Cited by 6
Vidal, P. M., Brockie, S. T., Farkas, C., Hong, J., Zhou, C., & Fehlings, M. G. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106640 · Cited by 6
Chen, Y., Wang, D., Liao, Y., Zuo, G., & Lu, X. (2024) · Discover Medicine · doi:10.1007/s44337-024-00135-2 · Cited by 5
Garg, G., Trisal, A., & Singh, A. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.020 · Cited by 6
Therapeutic strategies for Huntington’s disease: current approaches and future direction
Gulzar, M., Kauser, S., Khan, S., Adnan, M., & Hassan, M. I. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2552593 · Cited by 5
Mohammad, S. I., Hammood, Y. M., Vasudevan, A., Uthirapathy, S., Ballal, S., Sabarivani, A., Mishra, S., Nathiya, D., Al‐qaim, Z. H., & KADHIM, A. J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05447-7 · Cited by 6
Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease
Lin, G.-Y., Ma, C., Kuo, L.-C., Hsieh, B. Y., Wang, H., Liu, C., & Hsieh, M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00994-7 · Cited by 5
Srinivasan, S. R., de Gusmão, C. M., Korecka, J. A., & Khurana, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00048-4 · Cited by 6
Neuroprotective and gut health benefits of Ugni molinae in preclinical Huntington's disease models
Cisternas-Olmedo, M., Urra-Alvarez, V., Huerta, T. J., Urbina-Muñoz, V., Saavedra, B., Valdés, I., Riquelme, E. M., Sáez, M., Pérez-Arancibia, R., Delporte, C. L., et al. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115406 · Cited by 4
Sánchez-Migallón, P., Flores‐Cuadrado, A., Villanueva‐Anguita, P., Rábano, A., Vaamonde, J., Saiz‐Sánchez, D., Mohedano‐Moriano, A., Astillero‐Lopez, V., Soriano-Herrador, C., Martínez-Marcos, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf502 · Cited by 3
Maki, K. A., Barb, J. J., Xu, S., Papneja, S., Alkhatib, J., Butera, G., & Wallen, G. R. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106609 · Cited by 5
Roy, J. R., Janaki, C. S., Rajagopal, P., & Jayaraman, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_5 · Cited by 3
Mora-Ortiz, M., García-Fernández, H., Pérez‐Martínez, P., & Camargo, A. (2024) · Open Research Europe · doi:10.12688/openreseurope.18568.1 · Cited by 2
Alonso-García, P., Martín, R., & Martínez‐Pinilla, E. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00005 · Cited by 2
Neurodegenerative Diseases and the Gut Microbiota
Cabré, S., O’Riordan, K. J., & Cryan, J. F. (2022) · Progress in inflammation research · doi:10.1007/978-3-030-91051-8_11 · Cited by 2
Chen, X., Zhu, D., Ge, R., & Bao, Z. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116140 · Cited by 2
Yu-Taeger, L., El-Ayoubi, A., Qi, P., Danielyan, L., & Nguyen, H. P. (2024) · Cells · doi:10.3390/cells13060469 · Cited by 1
Nutraceutical interventions for neuroprotection: a comprehensive review
Ghosh, N., Ghosh, J., Ghosh, S., Sinha, K., & Sil, P. C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117637 · Cited by 2
Ghosh, A., Karmakar, V., Saha, B., Lye, A., Nandi, U., & Gorain, B. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06043-z · Cited by 1
Role of oral-gut-brain axis in psychiatric and neurological disorders
Duan, Z.-M., & Wu, L.-F. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i12.878 · Cited by 1
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_140 · Cited by 1
Gao, T., Jiang, B., Nian, Y., Bai, X., Zhong, J., Qin, L., Gao, Z., Wang, H., & Li, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4107823/v1 · Cited by 1
Gubert, C., Love, C. J., Kodikara, S., Liew, J. J. M., Renoir, T., Cao, K. L., & Hannan, A. J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3904352
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_140-1
Microbiome and Metabolomic Biomarkers for Huntington’s Disease
Masson, B. A., Qin, W., Love, C. J., Gubert, C., & Hannan, A. J. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_10
Role of microbiota-gut-brain axis in Huntington’s disease and possible interventions
Kumar, S., & Yadav, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00004-3 · Cited by 1
Zvyagina, V., Kuriakose, A., Simó, I., Kam, J. Y., Chakraborty, P., Robinson, K. J., Potapenko, A., Watchon, M., Paulsen, I. T., Gamage, H. K. A. H., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107121
Khodve, G., Raval, S., & Banerjee, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.015
Wu, J. Y., Zhang, X. Z., Zhang, Y., Zhang, R., Zhang, X., Liu, R. D., Long, S. R., Wang, Z. Q., & Cui, J. H. (2026) · The FASEB Journal · doi:10.1096/fj.202600314r
Targeting the microbiota-gut-brain axis in neurodegeneration: Zebrafish-based investigations
verma, B., Kumar, R., Sharma, A., Kumar, N., Khan, Z., Ashique, S., Rani, R., Parihar, V. S., Antal, S., Mumtaz, et al. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2705869
Simón‐Vicente, L., Lafont, M. O., Franch, M. A., Menéndez-Trillo, P., Rivadeneyra-Posadas, J. J., Miguel‐Pérez, I., Aguado, L., Muñoz‐Siscart, I., Díaz-Piñeiro, D., Mariscal, N., et al. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124617
The role of natural products in the intestinal barrier: a bibliometric analysis from 2004 to 2025
Hong, H., Hu, Y., Wang, C., & Zhu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1936472
Microbiota-derived metabolite-GPCR signalling in neurodegeneration
Sharma, A., & Jatana, N. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.09.001
Metadata
- Authors
- Stan, T. L., Soylu-Kucharz, R., Burleigh, S., Prykhodko, O., Cao, L., Franke, N., Sjögren, M., Haikal, C., Hållenius, F., & Björkqvist, M.
- Affiliations
- Lund University (SE)
- Corresponding author
- Soylu-Kucharz, Rana
- ORCID
- Venue
- Scientific Reports
- Published
- 2020-10-26
- Volume
- 10
- Issue
- 1
- Pages
- 18270-18270
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC7589489
- OpenAlex
- W3094034464
- Cited by
- 101
- References
- 48
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 22 · 2023: 17 · 2022: 26 · 2021: 11
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Royal Physiographic Society of Lund
- Per Westlings funds
- Knut och Alice Wallenbergs Stiftelse
- Svenska Sällskapet för Medicinsk Forskning
- The Direktör Albert Påhlsson Foundation, Sweden
- Vetenskapsrådet (#2017-01080)
- Lund University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Huntington's disease, intestinal permeability, gut dysbiosis, R6/2 mouse model, tight junction proteins, occludin, zonula occludens, gut microbiota, Bacteroidetes, Firmicutes, leaky gut, weight loss, colon length
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Body Weight, Disease Models, Animal, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Huntington Disease, Male, Phylogeny, RNA, Ribosomal, 16S, Sequence Analysis, DNA, Bacterial Physiological Phenomena, Bacterial Translocation, Mice, Tight Junction Proteins, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review